top of page
NEWS & EVENTS
SEE WHAT’S NEW AT QRITIVE—FROM BREAKTHROUGH STUDIES TO STRATEGIC COLLABORATIONS AND EVENT SHOWCASES.
Stay up to date with Qritive’s latest news, events, and announcements as we advance the future of digital pathology through global collaboration, scientific innovation, and clinical milestones.
Search
QAi Prostate Grade Receives Class C IVD Approval from Singapore’s Health Sciences Authority
Qritive is proud to announce that its AI-powered diagnostic solution, QAi Prostate Grade, has received Class C In Vitro Diagnostic (IVD) registration from Singapore’s Health Sciences Authority (HSA). This approval marks a major milestone in expanding the clinical use of artificial intelligence in prostate cancer diagnostics.Â
Aug 5
QAi Prostate Grade Receives Regulatory Approval from Abu Dhabi’s Department of Health
Qritive is pleased to announce that its AI-powered solution, QAi Prostate Grade, has received official market approval from the Department of Health – Abu Dhabi following a comprehensive Health Technology Assessment (HTA). This approval marks a major milestone in expanding the clinical use of artificial intelligence in prostate cancer diagnostics.Â
Jul 28
Qritive Recognized in Japan Smart Healthy Aging QuickFire Challenge
Singapore, July 1, 2025  — Qritive is proud to be selected as an awardee of the Japan Smart Healthy Aging QuickFire Challenge, an...
Jul 1
Qritive at ECDP 2025: Joint Presentation on AI-Powered Detection of Lymph Node Metastasis
Singapore, June 30, 2025  — Qritive participated in the European Congress on Digital Pathology (ECDP) 2025, held in Barcelona, Spain,...
Jun 30
Qritive at USCAP 2025: Presenting AI-Powered Study on Lymph Node Metastasis Detection
Qritive at USCAP 2025: Presenting AI-Powered Study on Lymph Node Metastasis Detection
Apr 2
Transforming Laboratory Diagnostics with AI – Qritive at Medlab Middle East 2025
Singapore, February 10, 2025  — Qritive participated in Medlab Middle East 2025, held from February 3–5 at the Dubai World Trade Centre,...
Feb 10
Enhancing Prostate Cancer Diagnosis with AI – Insights from the Uro-oncology Congress
Enhancing Prostate Cancer Diagnosis with AI – Insights from the Uro-oncology Congress
Jan 17
Driving AI Adoption in Pathology Across Europe – Highlights from the 11th Congress
Driving AI Adoption in Pathology Across Europe – Highlights from the 11th Congress
Dec 18, 2024
bottom of page